MultiPlan Corporation (MPLN) Stock
MPLN is no longer traded. MultiPlan was delisted from the NYSE in February 2025.
Prices on this page are historical; the last trade was February 28, 2025 at $20.99.
MultiPlan stock price history
MPLN final trading statistics
- Final close
- $20.99
- Final trading day
- Feb 28, 2025
- Market cap at delisting
- $340.00M
- Shares outstanding
- 16.20M
- Final 52-week range
- $0.17 – $29.84
- Avg. volume (final 3 mo.)
- 204,026
- All-time high (split-adj.)
- $478.80 · Jul 2020
- All-time low (split-adj.)
- $5.21 · Nov 2024
- Return since IPO
- -94.6%
- Beta
- 0.33
- Book value / share
- $5.19
- Price / book
- 4.04
MultiPlan annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $930.62M | -$1.6B | -$20.01 |
| FY2023 | $961.52M | -$91.7M | -$0.15 |
| FY2022 | $1.08B | -$572.9M | -$0.90 |
| FY2021 | $1.12B | $102.1M | $0.23 |
| FY2020 | $937.76M | -$529.6M | -$2.33 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About MultiPlan Corporation
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.
MultiPlan stock FAQ
What happened to MultiPlan stock?
MultiPlan stock was delisted from the NYSE. Its final close was $20.99 on February 28, 2025.
Is MPLN stock still trading?
No. MPLN was delisted from the NYSE in February 2025 and no longer trades on a U.S. exchange.
What was the last price of MPLN stock?
MPLN closed at $20.99 on its final trading day, February 28, 2025, for a market value of about $340.00M.
What were MultiPlan's revenue and earnings in its last full fiscal year?
MultiPlan reported revenue of $930.62M and net income of -$1.6B in fiscal 2024, its last full year as a public company.
When did MultiPlan go public?
MultiPlan Corporation stock began trading on April 3, 2020.